SOURCE: USDM Life Sciences

USDM Life Sciences

February 17, 2014 10:35 ET

USDM Life Sciences Vice President of Unique Device Identification Practice, Jay Crowley, Will Discuss UDI Final Rule at GS1 Global Forum

Jay Crowley Is the Architect of FDA's UDI Final Rule

SANTA BARBARA, CA--(Marketwired - Feb 17, 2014) - USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of USDM Life Sciences Unique Device Identification Practice, will discuss UDI regulations at the GS1 Global Forum in Brussels, Belgium on February 17th at 16:15 and February 19th at 13:30.

"As UDI rolls out globally, I'm looking forward to working closely with my colleagues at GS1 Global and the GS1 Member Organizations to help develop and implement global UDI standards," said Crowley. "All of us at USDM are looking forward to working with stakeholders to help their organizations implement UDI in a way that helps them realize the global benefits of UDI."

As Vice President of the UDI Practice at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage around UDI implementation.

Crowley held various positions over his nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA's Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA's Unique Device Identification System. 

The GS1 Global Forum is at the Crowne Plaza in Brussels, Belgium February 17-21, 2014.

About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 13 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit www.usdm.com.

Contact Information